Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | < 0.001 | 1 | 2001 | 2001 | ||||||
|
0.742 | 0.280 | 18 | 63153338 | intron variant | A/G | snv | 0.65 |
|
Mental Disorders | 0.020 | 0.500 | 2 | 2011 | 2013 | |||||||
|
0.742 | 0.280 | 18 | 63153338 | intron variant | A/G | snv | 0.65 |
|
Mental Disorders | 0.030 | 0.667 | 3 | 2011 | 2016 | |||||||
|
0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv |
|
Neoplasms | 0.060 | 1.000 | 6 | 2014 | 2017 | ||||||||
|
0.925 | 0.120 | 18 | 63178651 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 5 | 2016 | 2019 | |||||||||
|
0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv |
|
Neoplasms | 0.050 | 1.000 | 5 | 2014 | 2017 | ||||||||
|
0.925 | 0.120 | 18 | 63178651 | intron variant | T/A;C | snv |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.800 | 1.000 | 3 | 2012 | 2019 | ||||||||
|
0.925 | 0.080 | 18 | 63318285 | missense variant | C/T | snv | 2.4E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2002 | 2004 | |||||||
|
0.925 | 0.080 | 18 | 63318285 | missense variant | C/T | snv | 2.4E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2002 | 2004 | |||||||
|
0.925 | 0.120 | 18 | 63178651 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 2 | 2018 | 2019 | |||||||||
|
0.827 | 0.240 | 18 | 63212453 | intron variant | C/G;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.020 | 1.000 | 2 | 2013 | 2015 | ||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 2 | 2016 | 2019 | ||||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 2 | 2016 | 2019 | ||||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 2 | 2016 | 2019 | ||||||||||
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2007 | 2012 | ||||||
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Chemically-Induced Disorders | 0.020 | 1.000 | 2 | 2007 | 2007 | ||||||
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2007 | 2012 | ||||||
|
0.763 | 0.480 | 18 | 63318540 | missense variant | C/T | snv | 1.8E-02 | 4.9E-03 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2007 | 2012 | ||||||
|
0.724 | 0.320 | 18 | 63319604 | 5 prime UTR variant | G/A;T | snv |
|
Eye Diseases | 0.020 | 1.000 | 2 | 2015 | 2017 | ||||||||
|
0.925 | 0.040 | 18 | 63181406 | intron variant | T/A;C | snv |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 2 | 2015 | 2017 | ||||||||
|
0.925 | 0.040 | 18 | 63181406 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 2 | 2015 | 2017 | |||||||||
|
0.925 | 0.120 | 18 | 63126261 | 3 prime UTR variant | C/T | snv | 6.0E-02 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 2 | 2013 | 2016 | |||||||
|
0.925 | 0.120 | 18 | 63178651 | intron variant | T/A;C | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.925 | 0.120 | 18 | 63178651 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
0.925 | 0.120 | 18 | 63178651 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 |